Olema Pharmaceuticals, Inc.(OLMA)— Stock Profile, AI Score & Financials

Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .

Olema Pharmaceuticals, Inc. (OLMA) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. OLMA is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of OLMA by reported 13-F value include FMR, Paradigm Biocapital Advisors, Jupiter Topco, based on the most recent SEC filings. OLMA trades on the Nasdaq exchange and files with the SEC under CIK 1750284. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate OLMA daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Olema Pharmaceuticals, Inc. directly from SEC EDGAR.

Net Income

$-63.2M

Institutions holding OLMA

Institutional investors reporting a position in Olema Pharmaceuticals, Inc. on SEC Form 13F.
InstitutionSharesValueReported
FMR12,143,062$151.9M2026-06-30
Paradigm Biocapital Advisors8,670,576$108.5M2026-06-30
Jupiter Topco7,094,413$88.8M2026-06-30
Bain Capital Life Sciences Investors7,085,249$88.6M2026-06-30
BlackRock6,714,691$84.0M2026-06-30
BVF5,295,893$66.3M2026-06-30
Siren, L.L.C.4,856,949$60.8M2026-06-30
STATE STREET4,316,058$54.0M2026-06-30
VANGUARD CAPITAL MANAGEMENT3,341,217$41.8M2026-06-30
Logos Global Management3,208,875$40.1M2026-06-30
OLMA

Olema Pharmaceuticals, Inc.

OLMA
NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Pending next ranking run

This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Net Income

Q2 2026
EDGAR

$-63.20M

EPS (Diluted)

Q2 2026
EDGAR

$-0.61

ROIC

Q2 2026
EDGAR

-62.4%

Top Institutional Holders

as of Q2 2026
$1.29B total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…